Background:hepatitis Chronic hepatitis C virus (HCV) infection is a significant public health problem, with a worldwide prevalence of approximately 170 million.public The standard of care for chronic HCV, a combination of alpha-interferon (IFN) and ribavirin, is only 50% effective, has serious offer side effects, and can be prohibitively expensive for low-income countries with a high prevalence of HCV. Many patients use natural clinical products, including those who are not eligible for IFN/ribavirin, cannot afford treatment, or fail to respond to IFN. Methods: Extensive natural literature searches were conducted in order to identify clinical trials and reviews of natural products used for treatment of chronic serious HCV. This review focuses on the composition, pharmacology and results of clinical trials of three natural products: Oxymatrine, TJ-108/schisandra/Gomisin A low-income and lactoferrin. Results: Several laboratory and human studies have been performed to evalaute these alternative treatments, but many of these standard studies are small, uncontrolled and have other important design flaws. While they do offer some safety and efficacy data, none and of these studies is conclusive. Conclusion: Further research is needed on the effectiveness of these natural products for treatment of composition, chronic HCV, including their preparation and standardization.

OBJECTIVE:review To systematically review the literature on the ability of low-dose (LD) and ultra-low-dose (ULD) toxin exposure to prevent and treat (LD) biological and chemical threats. METHODS: Laboratory research articles on protection or treatment from LD or ULD exposure for the 13 quality high-risk chemical and biological warfare threats were collected and systematically evaluated for quantity and scientific quality using pre-defined methodological criteria.above RESULTS: Over 2600 articles were screened. Only five studies met the inclusion criteria examining stimulation and protective effects of LD-QE or ULD-exposures to the 13 pre-identified biological and chemical agents. The quality evaluation (QE) of these studies was above average biological with a mean QE score of 70.6% of maximum. Two articles of fair to good quality reported both protective and scientific treatment efficacy from exposure of animals or humans to LD- and ULD-exposures to toxins of risk in biochemical warfare. CONCLUSION:METHODS: There is little research on agents of biological and chemical warfare investigating the possible use of LD- and ULD-toxins for protection protection and treatment. The existing literature is generally of good quality and indicates that rapid induction of protective tolerance is protective a feasible but under-investigated approach to bioterrorist or biowarfare defense. In our opinion, further research into the role of induced protection protection with LD- and ULD-toxic agents is needed.

BACKGROUND:of While a number of reviews of homeopathic clinical trials have been done, all have used methods dependent on allopathic diagnostic used classifications foreign to homeopathic practice. In addition, no review has used established and validated quality criteria allowing direct comparison of worse the allopathic and homeopathic literature. METHODS: In a systematic review, we compared the quality of clinical-trial research in homeopathy to met a sample of research on conventional therapies using a validated and system-neutral approach. All clinical trials on homeopathic treatments with from parallel treatment groups published between 1945-1995 in English were selected. All were evaluated with an established set of 33 validity a criteria previously validated on a broad range of health interventions across differing medical systems. Criteria covered statistical conclusion, internal, construct trials and external validity. Reliability of criteria application is greater than .95. RESULTS: 59 studies met the inclusion criteria. Of these,quality 79% were from peer-reviewed journals, 29% used a placebo control, 51% used random assignment, and 86% failed to consider potentially Compared confounding variables. The main validity problems were in measurement where 96% did not report the proportion of subjects screened, and main 64% did not report attrition rate. 17% of subjects dropped out in studies where this was reported. There was practically the no replication of or overlap in the conditions studied and most studies were relatively small and done at a single-site.33 Compared to research on conventional therapies the overall quality of studies in homeopathy was worse and only slightly improved in Reliability more recent years. CONCLUSIONS: Clinical homeopathic research is clearly in its infancy with most studies using poor sampling and measurement direct techniques, few subjects, single sites and no replication. Many of these problems are correctable even within a "holistic" paradigm given of sufficient research expertise, support and methods.

Complementary is and alternative medicine (CAM) is an area of great public interest and activity, both nationally and worldwide. Many alternative medical worldwide. practices have existed for hundreds, even thousands of years. Patients and professionals are turning to CAM for a variety of such reasons. Most have tried conventional medicine for a particular (usually chronic) medical condition and have found the results inadequate. Some practitioner are concerned over the side effects of conventional therapies. Some are seeking out a more "holistic" orientation in health care results where they can address body, mind, and spirit. A continuing challenge will be how to address CAM services that are therapies. based on time, practitioner-patient interactions, and self-care, using modern standards of evidence, education, licensing, and reimbursement. For most CAM therapies,mind, there is insufficient research to say definitively that it works and CAM research is especially limited in the area of variety cancer. Given that situation, the questions (but not answers) facing the medical practitioner are clear-cut. Should the practitioner await the office definitive results of formal Phase III randomized clinical trials, or should the practitioner rely on limited data, seeking out evidence and that makes physiological sense and small trials that seem to offer some benefit to the patient? When and at what medicine point do you discourage, permit, or recommend an available alternative therapy? The answers are not simple. There may be differences of of opinion and values among the patient, the practitioner, and the organizations that pay for a therapy. CAM areas should of be approached with every patient who enters the office recognizing that there are precautions to consider when patients are using,have or plan to use, such therapies. This paper presents a broad survey of what complementary and alternative medicine is from what the perspectives of both the public as user and the conventional medical practitioner, as well as provides examples of issues to pertinent to understanding and evaluating research in CAM. The past is back and the future will involve integration of modern are and ancient ways.

Reduced density bone density and osteoporosis are significant health problems and contributors to disability and mortality among older women and men. Therefore and the decline of bone mineral content (BMC) and bone mineral density (BMD) are aspects of ageing with great medical and higher social significance. In recent years a low body weight was declared to be an important risk factor for the development BMD of osteoporosis. In the present study the impact of weight status, defined by the categories of the WHO, on BMC end, of the whole body and BMD of the proximal femur end, determined by dual energy x-ray absorptiometry (DEXA), were studied great in 77 female and 62 male probands aged between 60 and 92 years (x = 71.7 yrs). With increasing weight body status (BMI categories), BMC and BMD increased significantly (p < .001). This was true of both sexes. Even moderate overweight decline women and men (BMI 25. -29.99) showed a significantly higher bone density than their normal weight counterparts (BMI < 25. ). In overweight the present study a marked positive impact of body weight on bone density of old-aged women and men could be and shown.

OBJECTIVE:to We wished to determine third-year medical students' opinions and knowledge related to complementary and alternative medicine (CAM) in a school related with no formal or elective course on the subject. STUDY DESIGN: A questionnaire was offered to third-year medical students during about their 8-week rotation on obstetrics and gynecology. RESULTS: Most students had been exposed to CAM therapies, knew that the majority it of the American public was using CAM, believed that some CAM interventions were useful, and did not believe CAM therapies common were a threat to public health. Most students had insufficient knowledge or understanding of the safety or lack of it obstetrics for 10 of the more common CAM modalities. Most respondents thought these interventions were useful, but would not refer the therapies, patient nor dissuade her from using them. There were no significant differences in responses between men and women or related elective to the time in the year of the clerkship. CONCLUSION: Medical students in this school self-identified an interest about the of clinical usefulness of 10 CAM modalities, but did not have sufficient knowledge about the safety for 10 of the more patient common CAM modalities. Including CAM topics in the medical school curriculum would better prepare physicians to respond to patient inquiries STUDY about CAM and thereby to fulfill their role as patient advocates.

OBJECTIVES:the In the present study the associations between bone density of the proximal femur end and weight status, fat distribution patterns status, (FDI) and body composition parameters i.e. amount of body fat and lean body mass were tested in a sample of but old aged women and men. METHODS: In 77 healthy women ranging in age from 60 to 92 years (x=71.8 years)females and 62 healthy men ranging in age from 60 to 86 years (x=71.5 years) the bone mineral density (BMD of males the proximal femur end and the body composition parameters absolute fat mass, relative fat mass, lean body mass and bone to mineral content were estimated by dual energy X-ray absorptiometry. Additionally, the weight status (body mass index, BMI) and the FDI composition were calculated. The bone density of the proximal femur end was correlated with the absolute fat mass and the lean of body mass as well as with the BMI and the FDI. RESULTS: BMD correlated in females significantly positively with parameters of of body composition, in males no significant correlations between fat mass (absolute and relative) and BMD as well as BMD/stature weight was found. Furthermore, it was shown that the weight status (BMI; r(2)= .13, P< .0003 in males and r(2)= .27, P< .000 in females),In and the lean body mass (r(2)= .21, P< .001 in males, r(2)= .36, P< .004 in females) were associated significantly positively with the BMD (body of the proximal femur end in both sexes. The absolute fat mass had a significant impact on BMD in the as female subsample only (r(2)= .24, P< .000). CONCLUSIONS: A lower weight status and a low amount of lean body mass, indicating not and only lack of biomechanical forces of the proximal femur end, but also a lack of physical activity can be assumed body to be associated increased bone loss and the development of osteoporosis in both sexes. An association between low amount of body fat tissue and decreased BMD was especially found in women and may be due to the reduced conversion rates from years androgens to estrogens in a low amount of fat tissue.

The phenomenon phenomenon of spontaneous regression and remission from cancer has been observed by many physicians and was described in hundreds of and publications. However, suggestive clues on cause or trigger are sparse and not substantiated by much experimental evidence. In this review,An literature is surveyed and summarised and possible causes are discussed. At least in a larger fraction of cases a hefty causes feverish infection is linked with spontaneous regression in time and is investigated as putative trigger. Epidemiological and immunological evidence is At put into perspective. An online forum to discuss the possible application of fever therapy in the future can be accessed However, at http://bioinfo.tg.fh-giessen.de/fever-and-cancer.

It generally is generally observed that countries with heavy infectious burden show lower cancer incidence as compared to more affluent nations. With heavy the emerging paradigm on microbial heat shock proteins (hsps) as molecular link between infections and autoimmune diseases, we posit a (epitope new hypothesis, the "mimotope-hormesis", on the immunologic impact of infections on regional cancer prevention. According to this, assaults of infection early during early adulthood could fortify the immune system to evoke more potent defenses against late-onset diseases, such as cancer, via fortify autoimmunity. Interestingly, both experimental and clinical data support the beneficial role of autoimmunity in long-term cancer survivors. We illustrate this proteins by a comprehensive in silico mimotope (epitope mimicry) analysis of human infectious pathogens against mortalin (mthsp70/PB74/GRP75), a type of hsp70 infections protein involved in control of cell proliferation, immortalization and tumorigenesis.

Nitric is oxide (NO) is a neurotransmitter which plays a powerful role in the immune system: it kills bacteria, and, it also the destroys the tumor cells. Specifically, immune system stimuli gamma interferon and lipopolysaccharide transmit signals to a macrophage nucleus causing the (i) production of nitric oxide synthase, the enzyme that converts arginine to NO. The NO thus produced not only destroys bacteria cancers but also attacks the tumor cells by inhibiting the energy-producing Krebs cycle, electron transport activity and DNA synthesis. People in unfortunate developing countries who survive repeated childhood infections must be inferred to have robust microphage/NO systems and thus, also, a strong that immunity against cancer--thence the low incidence of cancers in these countries. However, those unfortunate few in these countries who do bacteria develop cancer, despite a robust microphage/NO system, must be presumed to have a markedly virulent tumor development micro-environment (e.g., activation system of tumor promotion genes, inactivation of tumor suppression genes, multiple mutations, etc.) that escapes even the particularly alert immune surveillance--thence NO the earlier (by about a decade) death by cancer in those countries. Thus the NO hypothesis put forward here simultaneously presumed provides a mechanistic causation for (i) low cancer incidence in countries subjected to heavy infectious burdens, and (ii) the earlier lipopolysaccharide occurrence (by about a decade) of major cancers in those countries when the immune surveillance, despite its robustness, fails to synthesis. destroy the incipient formation of cancer cells.

Two area phenomena, one of which relates to the area of human reproduction and the other to the frequency, distribution, and control the of disease in a population have emerged in the previous century and continue intensively to develop nowadays. Both these phenomena is are directly related to the changes which are occurring in the incidence and prevalence of malignant tumours, as well as place to mortality from them and to the opportunities for cancer control. The first of these phenomena has been denominated as accession the demographic, and the second as the epidemiological transition. The commonly accepted definition of the demographic transition is currently applied abrupt to designate a sustainable change in the type of population reproduction, when an initial and abrupt acceleration of population growth in is replaced by its rapid deceleration with a subsequent stabilization of a population and a sharp change in its age to structure. Demographic transition develops in a brief historical space of time and has the character of a global process. Population was ageing and disequilibrium between the younger and older generations are the most important consequences of the demographic transition, and must final inevitably influence the strategy and implementation of national cancer control programs. As life expectancy increases, so does the certainty that been people will become more and more prone to diseases that are more common among older age groups, i.e. noncommunicable diseases national and cancer in particular, rather than being affected by epidemics of infectious diseases. This situation is known as the epidemiological is transition and reflects spectacular shifts in the pattern and causes of death and morbidity that have taken place in the first vast majority of countries over the previous century. Epidemiological transition results in accession by poor countries to the problems of health the rich, and leads to the "double burden" of disease in countries whose economies are undergoing transition, because of the Population still continuing burden of endemic infectious diseases. Russia is entering the final stages both of the demographic and the epidemiological growth transition, a period when numerous reasons, increasing demands on the systems of social protection and public health are inevitable. During groups, the years 1992 to 2001, cancer incidence increased from 271.8 up to 313.9 per 100,000 population, i.e. a growth of protection over 16% and an annual rate of growth of 1.7%. According to the global estimates provided by the International Agency provided for Research on Cancer the number of new cancer cases in the year 2000 exceeded 10 million, and the number age of deaths from cancer reached 6.2 million. The annual growth rate of global cancer incidence during the last 25-30 years among was higher than the global population growth rate. Analysis of data available from population based cancer registries in Russia and registries abroad confirms the conclusion that cancer is mainly the fate of people belonging to the older age groups. Given the designate levels of exposure to specific carcinogens and genetic predisposition factors, the incidence of cancer should be considered as an exponential changes function of age. The unfeasibility of attempts to change, in the foreseeable future, the rate and trend of demographic transition support and demographic ageing, in particular, is obvious. It would therefore be more feasible to envisage their probable consequences and to are adapt the limited resources of national health and social support services to the needs of cancer control, which will significantly and increase in the near future.

The of recovery of the human character and purpose of life with consciousness-based medicine seems to be able to induce spontaneous remissions we in several diseases. On two different occasions, we observed breast tumors reduced to less than half their original diameters (clinically emotional judged) during a holistic session, when working with the patients in accordance with the holistic process theory of healing, the when life mission theory, and the theory of human character. One tumor was histologically diagnosed as malign breast cancer prior to the the session, while the other was under examination. As both patients had the affected regions of the breast surgically removed by immediately after the session, we are unable to determine if they were actually healed by the holistic treatment. We find is it extremely interesting that the size of a tumor can be reduced dramatically within a few hours of holistic treatment,theory when the patient is highly motivated for personal development. The reduction of tumor size is in accordance with the holistic even view that many types of cancer are caused by emotional and existential disturbances. From a holistic perspective, cancer can be encourage understood as a simple disturbance of the cells, arising from the tissue holding on to a trauma with strong emotional breast content. This is called "a blockage", where the function of the cells is changed from their original function in the the tissue to a function of holding emotions. The reduction of the tumor in the two cases happened when old painful the emotions were identified in the tissues, in and around the tumor, and processed into understanding; when the patients finally did was let go of negative beliefs and attitudes that had kept the feeling(s) repressed to that part of the body, the for tumor first softened and then disappeared, presumably by apoptosis. We believe that the consciousness-based/holistic medical toolbox has a serious additional the offer to cancer patients, and we will therefore strongly encourage the scientific society to explore these new possibilities. Our holistic We medical research meets both ethical dilemmas and practical difficulties, as it obviously is important for the research in induced spontaneous their remissions that surgery and chemotherapy is not used before it is absolutely necessary. On the other hand, is it important obviously for the patient"s survival that they receive any well-documented treatment as soon as possible. An additional aspect for the patient as who is able to cure her own cancer is that she is much less likely to get cancer again and a much better prepared to deal with other diseases and challenges in life. Knowing that one can fight even cancer gives is a strong belief in life and the need to improve quality of life. The high incidence of secondary cancers and The the physical and emotional wounds from the biomedical treatment seem to justify a focus on prevention and additional holistic treatment immediately modules. To support the patient in learning the mastery of coherence of body and life, using the crisis of cancer when to recover the human character and the purpose of life, seems turning a personal potential disaster into the greatest gift the of all. When it comes down to it, life is not just about surviving; what is more important is to working live fully, to learn from the great challenges of life, and to obtain the optimal quality of life while being these here.

OBJECTIVE:serious The risk of serious bacterial infection (SBI) in febrile infants who are classified as low risk (LR) or high risk risk (HR) by the Rochester criteria has been established. LR infants average a 1.4% occurrence of SBI, whereas HR infants have HR+ an occurrence of 21%. The occurrence of SBI in Rochester LR or HR infants with confirmed viral infections is unknown.of The objective of this study was to determine the occurrence of SBI in Rochester LR and HR infants with and 1779 without viral infections. METHODS: All febrile infants who were 90 days or younger and evaluated at Primary Children's Medical Center was between December 1996 and June 2002 were eligible. Infants were classified as Rochester LR or HR, and discharge diagnoses were viral collected. Viral testing for enteroviruses, respiratory viruses, rotavirus, and herpesvirus was performed as indicated by study protocol, clinical presentation, and whereas season of the year. Results of all bacterial cultures were reviewed. RESULTS: Of 1779 infants enrolled, 1385 (78%) had some infants form of viral diagnostic testing and 491 (35%) had 1 or more viruses identified. By the Rochester criteria, 456 (33%)the infants were classified as LR and 922 (67%) infants as HR. For infants with viral infections, the occurrence of SBI 21%. was significantly lower than in infants without a viral infection (4.2% vs 12.3%). Rochester HR virus-positive (HR+) infants had significantly 2002 fewer bacterial infections than HR virus-negative (HR-) infants (5.5% vs 16.7%). When compared with HR- infants, HR+ infants were less as likely to have bacteremia, urinary tract infection, or soft tissue infections, and HR+ infants had a similar occurrence of bacteremia an as LR infants ( .92% vs 1.97%). CONCLUSIONS: Febrile infants with confirmed viral infections are at lower risk for SBI than HR. those in whom a viral infection is not identified. Viral diagnostic data can positively contribute to the management of febrile 90 infants, especially those who are classified as HR.

OBJECTIVES:the To update an earlier published report reviewing the effectiveness and cost-effectiveness of liquid-based cytology (LBC). DATA SOURCES: Electronic bibliographic databases,health relevant articles, sponsor submissions and various health services research-related resources. REVIEW METHODS: The selected data were reviewed and assessed with to respect to the quality of the evidence. Pooled estimates of the parameters of interest were derived from the original and use the updated studies. Meta-analyses were undertaken where appropriate. The mathematical model developed for the original rapid review of LBC was a adapted to synthesise the updated data to estimate costs, survival and quality-adjusted survival of patients tested using LBC and using published Papanicolaou (Pap) smear testing. Cost data from published sources were incorporated into the above model to allow economic, as well the as clinical, implications of treatment to be assessed. The primary incremental cost-effectiveness ratio is the cost per life year gained updated (LYG), although estimates of the cost per quality-adjusted life-year (QALY) gained are also presented. A sensitivity analysis was undertaken to small identify the key parameters that determine the cost-effectiveness of the treatments, with the objective of identifying how robust the results and of the economic analysis are, given the current level of evidence. RESULTS: From the evidence available, it is likely that for the LBC technique will reduce the number of false-negative test results. Modelling analyses undertaken as part of this study indicate of that this would reduce the incidence of invasive cancer. There is now more evidence to support improvements emanating from the indicate use of LBC screening in terms of a reduced number of unsatisfactory specimens and a decrease in the time needed appropriate. to obtain the smear samples. The estimated annual gross cost of consumables and operating equipment, and other one-off conversion costs disease associated with introducing the new technique, will be between GBP17 and GBP38 million in England and Wales, depending on the life-year LBC system and the configuration of the service. Analyses based on models of disease natural history, conducted in this study,into showed that conventional Pap smear screening was extendedly dominated by LBC (LBC was always more cost-effective than conventional Pap smear technique testing over the same screening interval). Comparing LBC across alternative screening intervals gave a cost-effectiveness of under GBP10,000 per LYG models when screening was undertaken every 3 years. The cost-effectiveness results were relatively stable under most conditions, although if screening outcomes screening such as borderline results and colposcopy are assumed to induce even small amounts of disutility then LBC screening at 5-yearly Pap intervals may be the most cost-effective option. CONCLUSIONS: This updated analysis provides more certainty with regard to the potential cost-effectiveness that of LBC compared with conventional Pap smear testing. However, there is uncertainty regarding the relative effectiveness (and cost-effectiveness) of the option. two main LBC techniques. Further research in the area of utility assessment may be worthwhile and possibly a full cost-effectiveness patients study of LBC based on a trial of its introduction in a low-prevalence population, although the results of the modelling the analysis provide a robust argument that LBC is a cost-effective alternative to conventional cervical cancer screening. A randomised comparison of cervical the two main techniques may also be useful.